Expression of breast cancer stem cell markers as predictors of prognosis and response to trastuzumab in HER2-positive breast cancer

BACKGROUND: Breast cancer stem cells (BCSCs) have been suggested to have clinical implications for cancer therapeutics because of their proposed role in chemoresistance. The aim of this study was to investigate the impact of BCSC marker expression on clinical outcome and trastuzumab response in huma...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Br J Cancer
Prif Awduron: Seo, An Na, Lee, Hee Jin, Kim, Eun Joo, Jang, Min Hye, Kim, Yu Jung, Kim, Jee Hyun, Kim, Sung-Won, Ryu, Han Suk, Park, In Ae, Im, Seock-Ah, Gong, Gyungyub, Jung, Kyung Hae, Kim, Hee Jeong, Park, So Yeon
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Nature Publishing Group 2016
Pynciau:
Translational Therapeutics
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4865964/
https://ncbi.nlm.nih.gov/pubmed/27115469
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.101
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg